Beijing Baicare Closes $9 Million Round for Clinical Diagnostic Devices

Life Science

Nanjing Frontier Biotech Plans $285 Million IPO on Shanghai STAR Exchange

Life Science

FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs

Life Science

Qiyu Biotech of Shanghai Completes A Funding Round for Novel Biologics

Life Science

Bio-Thera Starts China Trials of a Third Arthritis Biosimilar

Life Science

DelMar Reports Positive Phase II Data from China Trial of GBM Treatment

Life Science

Chipscreen Bio Climbs 367% on First Trading Day following Shanghai IPO

Life Science

CStone Starts China Arm of Global RET Inhibitor Phase I Trial

Life Science

Aslan Presents Progress Update on its Three Clinical Candidates

Life Science

Deciphera Pharmaceuticals Announces Positive Top-line Results from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumors

Life Science

Shanghai’s Stemirna Raises $14 Million for RNA Drug Development

Life Science

Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China

Life Science

Ascletis Opens Clinical Development Shanghai Center

Life Science

Zai Lab Granted Expedited China Review for Brain Cancer Medical Device

Life Science

Vapo Health Completes Series A Round for Medical Device Business

Life Science